Topic - biopharma

avatar
Finance

Early-Stage VC Fuels Q3

M&A liquidity keeps venture market fluid.
avatar
Biosciences

Nasal Spray for Combat Wounds

Drug company Intranasal Therapeutics gets $39 million for a nose spray to ease battle wounds.
avatar
Biosciences

Tobacco’s Anti-Cancer Turn

As biomanufacturing heats up, a tiny company with big backing cooks up a way to use tobacco to fight the deadly disease.
avatar
Biosciences, Finance

Funding for Biotech Up in ’05

Biopharma and medical devices scored in 2005. Buyers want to get in early.